Pentagon mandates testosterone screening for male service members over 30

The Department of Defense has implemented mandatory screening guidelines for testosterone deficiency among male service members aged 30 and older, a move the Trump administration frames as essential to addressing national defense readiness. Adm. Brian Christine, a senior official at the Department of Health and Human Services, stated that low testosterone carries direct ramifications for military capability. The initiative follows a broader administrative push to rebuild the American military, which includes tightening fitness requirements, ending diversity, equity, and inclusion policies, and refocusing the force on combat lethality.

Christine, a urologist with over 35 years of experience in men's health, highlighted the shrinking pool of eligible recruits as a primary driver for the new guidelines. He noted that 77% of Americans between the ages of 17 and 24 do not qualify for military service without a waiver, citing obesity, chronic disease, and other barriers as contributing factors. Among young men specifically, he said more than 70% are ineligible for service, while only about 3% of young Americans express interest in enlisting. The administration views these demographic shifts as part of a decades-long decline in male health that impacts the physical demands placed on uniformed personnel.

Under the new Pentagon protocol, the screening process begins with an assessment of symptoms and risk factors. Further testing and potential treatment are available when medically appropriate. Christine emphasized that the administration is not mandating hormone therapy but is instead offering a pathway for symptomatic men with low hormone levels. He argued that testosterone levels are critical to men's overall well-being, lifespan, and mental health, noting that low levels are associated with higher rates of anxiety and depression.

Dr. Jay Bhattacharya, director of the National Institutes of Health, echoed concerns about undiagnosed deficiencies in a separate interview with Fox News Digital. Bhattacharya stated that epidemiological trends show testosterone levels in the American male population have declined over recent decades, though the specific causes remain unknown. He indicated that researchers must determine why these levels are dropping and what medical guidance should follow for diagnosis and treatment. Bhattacharya also pointed to declining sperm counts as another area requiring scientific investigation, suggesting that environmental exposures may be contributing to broader reproductive health issues.

Christine attributed part of the hormone decline to environmental factors, including microplastics and other toxins, though he noted these possibilities are still under investigation by researchers. He cited data indicating that average testosterone levels for men in the United States were well over 650 in the mid-1970s but are now approaching 350. The administration is currently developing separate hormonal health guidance for female service members, which the Defense Health Agency said will follow the September guidelines issued for male troops. Women's health specialists are contributing to these recommendations to ensure comprehensive care for all personnel.